Research Article

Effects of a Novel Glucokinase Activator, HMS5552, on Glucose Metabolism in a Rat Model of Type 2 Diabetes Mellitus

Figure 4

Effects of HMS5552 on GK immunoreactivity in the rat liver. Liver tissue sections stained with anti-GK antibody are shown at 200x magnification (a), and the number of GK-immunopositive cells was analyzed (b). HMS-L group, low-dose (10 mg/kg) HMS5552-treated diabetic group; HMS-H group, high-dose (30 mg/kg) HMS5552-treated diabetic group. The data are expressed as the mean ± SD (). and , compared with the control group; , compared with the diabetic group; , compared with the HMS-L group.
(a)
(b)